August brought a doubledose of good news to image processing software developer ISG Technologies.The company reported its first profitable quarter in three years,then followed that announcement with news that the Food and DrugAdministration granted
August brought a doubledose of good news to image processing software developer ISG Technologies.The company reported its first profitable quarter in three years,then followed that announcement with news that the Food and DrugAdministration granted 510(k) clearance to its line of image viewingworkstations.
The Canadian firm's financial comeback can be attributed toa new business plan that saw the firm expand from developing dedicated3-D workstations to pursuing OEM agreements for its software andviewing workstations (SCAN 12/15/93).
ISG recorded revenues for the fourth quarter (end-June) of$6.6 million, up 35% from $4.8 million in the same quarter a yearago. Income was $148,000 compared to a loss of $644,000 for thefourth quarter of 1993.
For the year, ISG had revenue of $20 million, a 9% increaseover the $18.4 million recorded in 1993. The company's loss for1994 was $2.1 million, compared to a loss of $1.7 million lastyear.
ISG, of Mississauga, Ontario, has lined up a number of OEMlicensing deals for its imaging applications platform (IAP) softwarefor developing custom applications. ISG also received Food andDrug Administration clearance in April for its Viewing Wand systemfor intraoperative image guidance (SCAN 5/4/94).
ISG had been waiting for word from the FDA on the third legof its product triangle, Family of Workstations (FoW). The companygot the FDA's nod this month.
FoW consists of four workstations:
** Silhouette, a second-console workstation for filming, archiving,image review and postprocessing;
** Digital Reading Station, a radiologist reading-room workstation;
** Digital Alternator, a physician viewing station; and
** Physicians Review Station, a workstation for remote imageviewing, both inside and outside the hospital.
ISG has been in discussions with Du Pont concerning an OEMarrangement between the firms (SCAN 4/20/94). In a letter to stockholders,ISG said it was involved in negotiations with several large radiologyfilm companies, and expected to make an announcement about thenegotiations shortly.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.